Related Experiment Video
Updated: Feb 20, 2026
11:35
The Multiple Sclerosis Performance Test MSPT: An iPad-Based Disability Assessment Tool
Published on: June 30, 2014
58.8K
Using IMPrESS to guide policy change in multiple sclerosis.
Michela Tinelli1, Panos Kanavos1, Olina Efthymiadou1
1Department of Health Policy, The London School of Economics and Political Science, London, UK.
Multiple Sclerosis (Houndmills, Basingstoke, England)
|October 25, 2017
Summary
The International Multiple Sclerosis Study (IMPrESS) highlights the significant socioeconomic burden of multiple sclerosis (MS). Early diagnosis and disease-modifying treatments (DMTs) are crucial for improving patient outcomes and quality of life.
Area of Science:
- Neurology
- Public Health
- Health Economics
Background:
- Multiple sclerosis (MS) significantly impacts patients, caregivers, and society.
- Existing management strategies may not fully address the comprehensive burden of MS.
Purpose of the Study:
- To present international evidence on the socioeconomic burden of MS.
- To discuss a paradigm shift in MS management for improved outcomes.
Main Methods:
- Utilized data from the International Multiple Sclerosis Study (IMPrESS).
- Analyzed socioeconomic impact and explored diagnostic and treatment advancements.
Main Results:
- Confirmed the substantial socioeconomic burden associated with MS.
- Identified an urgent need for enhanced patient outcomes.
Conclusions:
- A paradigm shift towards earlier diagnosis and proactive use of disease-modifying treatments (DMTs) is warranted.
- Improved monitoring and timely treatment can lead to better clinical, quality-of-life, and socioeconomic results for individuals with MS.
Related Concept Videos
01:21EPS and iPS Cells in Disease Research
3.4K
Embryonic and induced pluripotent stem cells are excellent models for disease research because of their ability to self-renew and differentiate into most cell types. Somatic cells from a patient are isolated and reprogrammed into induced pluripotent stem cells or iPSCs. These iPSCs are later differentiated into the desired cell type, which mirrors the diseased cell of the patient. In this way, disease models have been created for investigating diseases such as Down syndrome, type I diabetes,...
3.4K
01:20Myasthenia Gravis: Overview and Treatment
3.1K
Myasthenia gravis is a neuromuscular transmission disorder characterized by weakness and increased fatigability of skeletal muscles. It is an autoimmune disease affecting approximately one in 2000 people, where antibodies against the α1 subunit of nicotinic acetylcholine receptors are produced.
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
These antibodies interfere with the function of the nicotinic receptors in three ways: by binding to the receptor and disrupting acetylcholine binding; by causing cross-linking of receptors which...
3.1K
01:22iPS Cell Differentiation
3.2K
The ability of induced pluripotent stem cells or iPSCs to differentiate into most body cell types has stimulated repair and regenerative medicine research over the past few decades. iPSC-derived blood cells, hepatocytes, beta islet cells, cardiomyocytes, neurons, and other cell types can repair injuries or regenerate damaged tissue in diseases such as diabetes and neurodegenerative disorders.
3.2K